One prominent example of pharmacoepidemiology is the surveillance of (). In the late 1950s and early 1960s, () was marketed as a safe sedative, but it was linked to severe birth defects. Pharmacoepidemiological studies in the years following its release helped raise awareness about the drug’s dangers, leading to tighter regulations and better safety monitoring for new medications.